Skip to main content
. Author manuscript; available in PMC: 2019 Aug 21.
Published in final edited form as: Expert Rev Anticancer Ther. 2017 Apr 27;17(6):527–535. doi: 10.1080/14737140.2017.1316197

Figure 1.

Figure 1.

Extracellular and intracellular adenosine pathways. CD73, a 5′-ectonucleotidase, is a rate controlling enzyme of the extracellular ADO pathway. CD73, as soluble or exosomal 5′–nucleotidase, also produces intracellular ADO from AMP. ADO signals via four P1 purinergic receptors expressed on a wide variety of cell types. The figure is modified and reproduced with permission from ref. 17.